Dan Van Fleet

San Francisco | Silicon Valley
  • 505 Montgomery Street
  • Suite 2000
  • San Francisco, CA 94111-6538
  • USA
Profile Experience

Dan Van Fleet represents borrowers and lenders as well as venture capital and private equity firms with respect to debt financings, with a focus on the technology and life sciences industries.

Mr. Van Fleet draws on experience representing clients on all sides of debt financing transactions to deliver insightful counsel to borrowers, sponsors, and financial institutions. He has advised on billions of dollars’ worth of debt transactions, including:

  • Growth debt, including venture, structured, royalty, and lower middle market
  • Private equity, growth equity, and leveraged financings, including acquisitions, add-ons, and refinancings
  • Asset-based transactions, including leasings
  • Structured equity and pre-IPO financings

Mr. Van Fleet is a member of the firm’s Training and Career Enhancement Committee.

In law school, he was an editor on the Duke Law Journal and Duke Law & Technology Review. He is a member of the Stanford and Duke Law alumni networks and is actively involved with Stanford's Bing Overseas Study Program and Duke's Law & Entrepreneurship Program and Center on Law and Technology.


Mr. Van Fleet has advised on a variety of debt transactions in the technology industry, including those involving cloud services, artificial intelligence (AI), and agtech. A representative sample of his clients includes:

  • Actifo
  • AdRoll
  • Airbnb
  • Airgain
  • AppIQ
  • Bright Machines
  • Brilliant Earth
  • Cartera
  • Clarabridge
  • Delivery Agent
  • Desktop Metal
  • Dolls Kill
  • Drift, Inc.
  • Filevine
  • Hearsay Social
  • Heliotrope Technologies
  • HotelTonight
  • Joby Aviation
  • Light
  • LiquidSpace
  • LogMeIn
  • Memphis Meats
  • Mosaic
  • Nasuni
  • Nozomi Networks
  • Ouster
  • Shift Technologies
  • Soraa
  • Stion
  • Synack
  • Tealium
Life Sciences

Mr. Van Fleet has advised on a variety of debt transactions in the healthcare and life sciences industries, including those involving medical device manufacturers, and pharmaceutical and biotech companies. A representative sample of his clients includes:

  • ArcherDX
  • BIND Therapeutics
  • Codexis
  • Eargo
  • Evoke Pharma
  • Frequency Therapeutics
  • Gingko Bioworks
  • Gossamer Bio
  • SmartyPants Vitamins
  • Tizona Therapeutics
  • Zogenix
  • Zosano Pharma
Venture Capital and Private Equity

Mr. Van Fleet regularly represents venture capital and private equity firms in connection with private and public investments, acquisitions, and divestitures. His clients include:

  • 8VC
  • Formation 8
  • Khosla
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.